Israeli scientists are turning their focus to how breast cancer spreads which could lead to improvements in treatment and survivability.

The doctors suggested Tamir Gilat make a farewell trip. But a decade later he is thriving thanks to groundbreaking Israeli researches he now strives to fund

Researchers are studying how tumors thrive and spread, despite the defenses of the immune system.

‘Israel has become a major source of innovation in the understanding and treatment of cancer,’ says director of Israel Cancer Research Fund.

ICRF has a long history of supporting fundamental laboratory science that provides the foundation for work with clinical impact.

ICRF hopes new donations, at $4.3 million, will encourage the Jewish state to continue to serve as ‘a major source of innovation’